Jill O'Donnell-Tormey, CEO and Director of Scientific Affairs, is a panelist for the Fierce BioTech virtual roundtable.
Cancer experts will highlight closely watched data sets to be unveiled at ASCO. This discussion will take a close look at oncology's hottest fields, including CAR-T and precision medicine, as panelists zero in on the conference's most highly anticipated studies, 2021's biggest research trends, and the data they're most looking forward to seeing.
Jill O’Donnell-Tormey, Ph.D.
Chief Executive Officer and Director of Scientific Affairs
Cancer Research Institute
Jennifer Keating Litton, M.D.
Vice President of Clinical Research and Professor
The University of Texas MD Anderson Cancer Center
Joseph Alvarnas, M.D.
Vice President for Government Affairs, Chief Clinical Advisor
Clinical Professor, Department of Hematology & Hematopoietic Cell Transplantation
City of Hope
Photo by Wolfgang Hasselmann on Unsplash